{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:34:40Z","timestamp":1790386480332,"version":"4.1.0"},"reference-count":30,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005440","name":"Center for Scientific Review","doi-asserted-by":"publisher","award":["UL1TR002489"],"award-info":[{"award-number":["UL1TR002489"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005440","name":"Center for Scientific Review","doi-asserted-by":"publisher","award":["P30DK124723"],"award-info":[{"award-number":["P30DK124723"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Despite advances in exogenous insulin therapy, many patients with type 1 diabetes do not achieve acceptable glycemic control and remain at risk for ketosis and insulin-induced hypoglycemia. We conducted a randomized controlled trial to determine whether TTP399, a novel hepatoselective glucokinase activator, improved glycemic control in people with type 1 diabetes without increasing hypoglycemia or ketosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>SimpliciT1 was a phase 1b\/2 adaptive study. Phase 2 activities were conducted in two parts. Part 1 randomly assigned 20 participants using continuous glucose monitors and continuous subcutaneous insulin infusion (CSII). Part 2 randomly assigned 85 participants receiving multiple daily injections of insulin or CSII. In both parts 1 and 2, participants were randomly assigned to 800 mg TTP399 or matched placebo (fully blinded) and treated for 12 weeks. The primary end point was change in HbA1c from baseline to week 12.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The difference in change in HbA1c from baseline to week 12 between TTP399 and placebo was \u22120.7% (95% CI \u22121.3, \u22120.07) in part 1 and \u22120.21% (95% CI \u22120.39, \u22120.04) in part 2. Despite a greater decrease in HbA1c with TTP399, the frequency of severe or symptomatic hypoglycemia decreased by 40% relative to placebo in part 2. In both parts 1 and 2, plasma \u03b2-hydroxybutyrate and urinary ketones were lower during treatment with TTP399 than placebo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>TTP399 lowers HbA1c and reduces hypoglycemia without increasing the risk of ketosis and should be further evaluated as an adjunctive therapy for the treatment of type 1 diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc20-2684","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T11:05:20Z","timestamp":1614078320000},"page":"960-968","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":39,"title":["The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b\/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes"],"prefix":"10.2337","volume":"44","clinical-trial-number":[{"clinical-trial-number":"nct03335371","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5894-9054","authenticated-orcid":false,"given":"Klara R.","family":"Klein","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.R.","family":"Freeman","sequence":"additional","affiliation":[{"name":"vTv Therapeutics LLC, High Point, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imogene","family":"Dunn","sequence":"additional","affiliation":[{"name":"vTv Therapeutics LLC, High Point, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Dvergsten","sequence":"additional","affiliation":[{"name":"vTv Therapeutics LLC, High Point, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-9609","authenticated-orcid":false,"given":"M. Sue","family":"Kirkman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Buse","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Valcarce","sequence":"additional","affiliation":[{"name":"vTv Therapeutics LLC, High Point, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SimpliciT1 research group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara R.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sue","family":"Kirkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Bergamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Dostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Machineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie C.","family":"Diner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milana","family":"Dezube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia C.","family":"Purrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Uehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael M.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer V.","family":"Rowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Jean","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Snedaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Becton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Hainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Garcia-Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Vance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie","family":"Stifel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa B.","family":"Connery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birjis","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Zweier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kronenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Savoca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viral N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakriti","family":"Joshee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halis Kaan","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbulaxami","family":"Trikudanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dori","family":"Khakpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Cohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Harmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S","family":". Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"2022031309374278500_B1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2022031309374278500_B2","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.2337\/dc20-S006","article-title":"6. Glycemic targets: Standards of Medical Care in Diabetes\u20142020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031309374278500_B3","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2337\/dci18-0004","article-title":"Increasing hospitalizations for DKA: a need for prevention programs","volume":"41","author":"Vellanki","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031309374278500_B4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00018-008-8322-9","article-title":"Molecular physiology of mammalian glucokinase","volume":"66","author":"Iynedjian","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"2022031309374278500_B5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/356162a0","article-title":"Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus","volume":"356","author":"Froguel","year":"1992","journal-title":"Nature"},{"key":"2022031309374278500_B6","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0140-6736(92)91958-B","article-title":"Linkage of type 2 diabetes to the glucokinase gene","volume":"339","author":"Hattersley","year":"1992","journal-title":"Lancet"},{"key":"2022031309374278500_B7","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.2337\/diabetes.52.11.2854","article-title":"Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway","volume":"52","author":"Nj\u00f8lstad","year":"2003","journal-title":"Diabetes"},{"key":"2022031309374278500_B8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJM199801223380404","article-title":"Familial hyperinsulinism caused by an activating glucokinase mutation","volume":"338","author":"Glaser","year":"1998","journal-title":"N Engl J Med"},{"key":"2022031309374278500_B9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diabetes.47.3.307","article-title":"Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities","volume":"47","author":"Matschinsky","year":"1998","journal-title":"Diabetes"},{"key":"2022031309374278500_B10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fphys.2019.00148","article-title":"The central role of glucokinase in glucose homeostasis: a perspective 50 Years after demonstrating the presence of the enzyme in islets of langerhans","volume":"10","author":"Matschinsky","year":"2019","journal-title":"Front Physiol"},{"key":"2022031309374278500_B11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1432-1033.1990.tb19147.x","article-title":"The mechanism by which rat liver glucokinase is inhibited by the regulatory protein","volume":"191","author":"Vandercammen","year":"1990","journal-title":"Eur J Biochem"},{"key":"2022031309374278500_B12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1432-1033.1991.tb16217.x","article-title":"Competitive inhibition of liver glucokinase by its regulatory protein","volume":"200","author":"Vandercammen","year":"1991","journal-title":"Eur J Biochem"},{"key":"2022031309374278500_B13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1042\/bj2940551","article-title":"Species and tissue distribution of the regulatory protein of glucokinase","volume":"294","author":"Vandercammen","year":"1993","journal-title":"Biochem J"},{"key":"2022031309374278500_B14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0014-5793(99)00971-0","article-title":"Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase","volume":"456","author":"de la Iglesia","year":"1999","journal-title":"FEBS Lett"},{"key":"2022031309374278500_B15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2337\/diab.46.2.179","article-title":"Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus","volume":"46","author":"Brown","year":"1997","journal-title":"Diabetes"},{"key":"2022031309374278500_B16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14728222.2014.965681","article-title":"Molecular targeting of the GK-GKRP pathway in diabetes","volume":"19","author":"Hale","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"2022031309374278500_B17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mehy.2016.08.002","article-title":"In type 1 diabetics, high-dose biotin may compensate for low hepatic insulin exposure, promoting a more normal expression of glycolytic and gluconeogenic enyzymes and thereby aiding glycemic control","volume":"95","author":"McCarty","year":"2016","journal-title":"Med Hypotheses"},{"key":"2022031309374278500_B18","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1089\/10430340260201653","article-title":"Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes","volume":"13","author":"Morral","year":"2002","journal-title":"Hum Gene Ther"},{"key":"2022031309374278500_B19","doi-asserted-by":"crossref","first-page":"eaau3441","DOI":"10.1126\/scitranslmed.aau3441","article-title":"Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator","volume":"11","author":"Vella","year":"2019","journal-title":"Sci Transl Med"},{"key":"2022031309374278500_B20","unstructured":"European Medicines Agency Committee for Medicinal Products for Human Use\n          . Reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design. Accessed 22 December 2020. Available from https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-methodological-issues-confirmatory-clinical-trials-planned-adaptive-design_en.pdf"},{"key":"2022031309374278500_B21","unstructured":"Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research\n          , Eds. Adaptive design for clinical trials of drugs and biologics: guidance for industry. Accessed 22 December 2020. Available from https:\/\/www.fda.gov\/media\/78495\/download"},{"key":"2022031309374278500_B22","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2337\/db14-0059","article-title":"Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia","volume":"63","author":"Cryer","year":"2014","journal-title":"Diabetes"},{"key":"2022031309374278500_B23","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1073\/pnas.93.14.7225","article-title":"Correction of diabetic alterations by glucokinase","volume":"93","author":"Ferre","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031309374278500_B24","unstructured":"Valcarce\u2008C\n          . Selective activation of glucokinase (GK) in the liver: improves glycemic control and reduces insulin need as well as risk of ketoacidosis in type 1 diabetic minipigs. Accessed 19 August 2020. Available from https:\/\/vtvtherapeutics.com\/wp-content\/uploads\/2020\/08\/GKA-Poster-Keystone-2017_01182017_final-minipigs.pdf"},{"key":"2022031309374278500_B25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4239\/wjd.v10.i4.234","article-title":"Pharmacologic adjunctive to insulin therapies in type 1 diabetes: the journey has just begun","volume":"10","author":"Karras","year":"2019","journal-title":"World J Diabetes"},{"key":"2022031309374278500_B26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2337\/dc16-0690","article-title":"Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial","volume":"39","author":"Ahr\u00e9n","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031309374278500_B27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(19)30154-8","article-title":"SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031309374278500_B28","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/dc16-0691","article-title":"Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial","volume":"39","author":"Mathieu","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031309374278500_B29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s13300-017-0282-3","article-title":"Effects of insulin plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in treating type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Diabetes Ther"},{"key":"2022031309374278500_B30","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/dc20-0924","article-title":"Diabetic ketoacidosis and related events with sotagliflozin added to insulin in adults with type 1 diabetes: a pooled analysis of the inTandem 1 and 2 studies","volume":"43","author":"Peters","year":"2020","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc20-2684","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/4\/960\/632083\/dc202684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/4\/960\/632083\/dc202684.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T10:50:08Z","timestamp":1647168608000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/44\/4\/960\/138590\/The-SimpliciT1-Study-A-Randomized-Double-Blind"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc20-2684","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,23]]}}}